Rensselaer Researchers Receive $3.5 Million Grant for Development of COVID Antiviral Drug
Rensselaer Polytechnic Institute (RPI)Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop a low-dose, oral COVID antiviral drug that can be administered at home.